» Articles » PMID: 12849929

Involvement of Serotonin in Depression: Evidence from Postmortem and Imaging Studies of Serotonin Receptors and the Serotonin Transporter

Overview
Journal J Psychiatr Res
Specialty Psychiatry
Date 2003 Jul 10
PMID 12849929
Citations 104
Authors
Affiliations
Soon will be listed here.
Abstract

Definitive conclusions on the role of serotonin receptors and transporter in suicide and depression have been elusive in studies of postmortem brain tissue. A number of methodological differences in these studies have made it difficult to reach a consensus, but crucial issues are being identified and incorporated into newer studies. This review will follow the evolution of serotonin receptor and transporter studies in postmortem tissues that initially focused on suicide and gradually incorporated depressive disorders as psychiatric assessments were increasingly performed. Studies in postmortem tissues on the serotonin-1A and serotonin-2A receptors and the serotonin transporter will be reviewed and compared with imaging studies of the same sites in depressed subjects. Critical issues to control in future studies of serotonin receptors in postmortem tissues include variables such as the cause of death (i.e. suicide), the specific psychiatric diagnoses of the subjects, whether the disorder was in remission at the time of death, long-term medication histories, psychoactive substance use disorders, the smoking history, the hemisphere from which tissues were dissected, and the specific cytoarchitectonic region to be evaluated. Carefully controlled studies in postmortem tissues will ensure a greater likelihood of reaching a consensus on the involvement of monoamine measures in the etiology of depression.

Citing Articles

Metabolomics in Depression: What We Learn from Preclinical and Clinical Evidences.

Singh P, Vasundhara B, Das N, Sharma R, Kumar A, Datusalia A Mol Neurobiol. 2024; 62(1):718-741.

PMID: 38898199 DOI: 10.1007/s12035-024-04302-5.


Alterations in adolescent brain serotonin (5HT), 5HT, and dopamine (D) receptor systems in a nonhuman primate model of early life adversity.

Wakeford A, Nye J, Morin E, Mun J, Meyer J, Goodman M Neuropsychopharmacology. 2024; 49(8):1227-1235.

PMID: 38671147 PMC: 11224234. DOI: 10.1038/s41386-023-01784-0.


Anxiety and depression: A top-down, bottom-up model of circuit function.

LeDuke D, Borio M, Miranda R, Tye K Ann N Y Acad Sci. 2023; 1525(1):70-87.

PMID: 37129246 PMC: 10695657. DOI: 10.1111/nyas.14997.


In vivo serotonin transporter and 1A receptor binding potential and ecological momentary assessment (EMA) of stress in major depression and suicidal behavior.

Bartlett E, Zanderigo F, Stanley B, Choo T, Galfalvy H, Pantazatos S Eur Neuropsychopharmacol. 2023; 70:1-13.

PMID: 36780841 PMC: 10121874. DOI: 10.1016/j.euroneuro.2023.01.006.


serotonin 1A receptor hippocampal binding potential in depression and reported childhood adversity.

Bartlett E, Yttredahl A, Boldrini M, Tyrer A, Hill K, Ananth M Eur Psychiatry. 2023; 66(1):e17.

PMID: 36691786 PMC: 9970152. DOI: 10.1192/j.eurpsy.2023.4.